Logo image

Lutetium-177 PSMA Therapy for Prostate Cancer - 1 cycle | Döbling Private Clinic, Vienna, Austria

Lutetium-177 PSMA Therapy for Prostate Cancer - 1 cycle | Döbling Private Clinic, Vienna, Austria

Vienna, Austria

User ScoreRatingMedia Files


Age group


Type of care




About the offer

LU 177 PSMA treatment aims to kill cancer cells by beta radiation of the isotope Lutetium-177. The radioactive particle binds explicitly to prostate cancer cells regardless of their location. As a result, the drug destroys the primary tumor and distant metastases. Doctors take blood tests and examine liver and kidney functions before the procedure. But, first, a Ga68-PSMA scan is performed to detect all metastases and determine how well the particular malignant cells accumulate PSMA drug. The patient is injected intravenously for 20 minutes with the Lutetium medication. After that, he stays in a closed ward protected from radiation for two days because he is a beta radiation source. During the action of the radionuclide, he receives drugs to protect the thyroid gland and kidneys, and copious drinking, if necessary, means to reduce nausea and vomiting.  The patient can take personal belongings to the ward. They will not become radioactive. The zone of radiation does not exceed 1 millimeter. A day after the therapy, the patient is given a control examination, dosimetry, and kidney scintigraphy. Doctors achieve reduced prostate cancer metastases up to complete remission as Lu 177 treatment results. However, repeating a couple of sessions at 1-2 months intervals might be required.

What’s included

Medical service

  • clinical history-taking
  • medical records review
  • physical examination
  • consultation with a nuclear medicine specialist
Laboratory tests
  • complete blood count (CBC)
  • biochemical analysis of blood (kidney and liver function tests, electrolytes)
  • inflammation blood tests
  • urinalysis
  • PSA test
  • renal scintigraphy with 99mTc-MAG3
  • pre-procedure patient preparation
  • Lutetium-177 PSMA-DKFZ 617 radioligand therapy
  • post-procedure care
  • control examinations
  • symptomatic treatment
  • cost of radiopharmaceuticals
  • cost of essential medicines
  • cost of essential materials
  • outpatient admission
  • nursing service
  • discharge medical records
  • further recommendations
Distant service
  • support after the therapy to evaluate the treatment results and subsequent blood tests

Extra add-ons

Local transportation
Airport transfer
Personal coordinator
HealthDocs translate
Language Assistance


AiroMedical support
Payment protection
Patient advocacy
Price match

Meet the provider

Univ. Prof. Dr. med. Werner Langsteger

theranostics, nuclear medicine, diagnostics, prostate and thyroid cancer


Why to choose us?

Unique, specialized team
The Theranosticum Vienna, under the guidance of Univ.-Prof. Dr. Marcus Hacker, Univ.-Prof. Dr. Werner Langsteger, and Univ.-Prof. Mag. Markus Mitterhauser, specializes in nuclear medicine diagnostics and outpatient personalized therapies for various types of cancer. They are located at the Institute for Nuclear Medicine and Isotope Diagnostics at the Döbling Ambulatory and Vienna General Hospital for inpatient stay.
Personalized approach
The THERANOSTICS principle "we treat what we see" means that what was previously visible is treated. This principle enables a personalized therapy decision with radio ligand therapy, which is made exclusively in close coordination between the treating physician and the patient. Together, a suitable radiopharmaceutical is selected that binds selectively and with high precision to the surface of tumor cells, thus specifically destroying tumors and metastases while minimizing damage to the surrounding healthy tissue.
Life-changer for metastatic prostate cancer
The treatment can significantly increase the quality of life and extend the life span due to its good tolerability. Numerous studies have shown that it can produce good results, particularly in treating prostate cancer.


Customize this offer

If you're not seeing exactly what you need here, send your custom request. You can discuss the content, specifics, price & timeline to create a personalized plan.


Heiligenstädter Str., 55-63, 1190 Vienna Austria


What is nuclear medicine?

Nuclear medicine is a medical specialty that employs small amounts of radioactive materials, also known as radioactive isotopes or radioisotopes, to diagnose and treat various diseases. These radioactive materials are used as radiotracers for diagnostics, such as 68Gallium, and radiopharmaceuticals for treatment, such as 177Lutetium. Nuclear medicine is commonly utilized to diagnose and treat cancer. Theranostics is a specialized field of nuclear medicine.

What is the cost?

The total price for Lutetium-177 PSMA Therapy for Prostate Cancer - 1 cycle | Döbling Private Clinic, Vienna, Austria is €29,612. However, it can vary from the specifics of each case. Get in touch to get an individual estimate.

What is the rating of the offer?

Lutetium-177 PSMA Therapy for Prostate Cancer - 1 cycle | Döbling Private Clinic, Vienna, Austria is rated as 9.70 by AiroMedical.

Who is offering a deal?

How long does the offer take?

The offer is designed for 4 days.

Does the offer require you to stay in the clinic overnight?

What are the age restrictions?

The offer is eligible only for adults.

Can I customize the content of the offer?

Yes, the components of the deal can be changed. Get in touch with a vendor to create a personalized proposal.

Does the offer include extra services?

Lutetium-177 PSMA Therapy for Prostate Cancer - 1 cycle | Döbling Private Clinic, Vienna, Austria has 13 add-ons and unique AiroCare services for AiroMedical users.

Individual cost estimate. Non-binding 100% free assessment.


Similar deals